$17.40 $0.19 per serving
Product analysis
Astaxanthin 4 mg offers a favorable cost for astaxanthin, with limited support for maintaining selected aspects of skin condition.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality38
The algae source is identified, but a reliable comparison of preparation quality is unavailable. The unidentified extra entry does not establish another active ingredient.
Ingredient Transparency81
The astaxanthin amount and algae source support comparison of its main ingredient. A separate unidentified entry adds no clear active detail.
Value For Money100
The cost is favorable for the active astaxanthin amount. Value on that basis does not establish that every intended use will benefit.
Customer Satisfaction88
Customer ratings are very positive across a large body of feedback. They describe satisfaction rather than establishing health benefits.
Product Focus68
The most relevant findings concern selected skin measures. The lower serving does not match every exposure behind the wider eye or skin findings, so expectations should remain modest.
- Format
Softgel - Container
- 90 Softgel(s)
- Per serving
- $0.19
- Also available
Extra Strength Astaxanthin 10 mg$18.32- Customer rating
- 4.7 · 5,586 ratings
Goals
Impact
High effect
Astaxanthin · 4 mg
Astaxanthin has antioxidant activity and a limited inflammation-marker signal from a small trial in healthy young women. The positive CRP finding at 2 mg per day did not translate into a consistent dose-response pattern; higher exposure did not uniformly improve inflammatory markers. The saved amount recognition therefore does not establish clinical benefit from this serving.
How this product is rated for Inflammation
Ingredient fit73
The relevant active is concentrated in this product, although its uses extend beyond inflammation. The selected serving receives partial amount recognition relative to the saved comparison, without establishing a clinical dose.
Goal fit
The relevant active is concentrated in this product, although its uses extend beyond inflammation.
Dose adequacy
The selected serving receives partial amount recognition relative to the saved comparison, without establishing a clinical dose.
Pathways16
The main assigned contribution concerns oxidative and mitochondrial stress; this classification does not prove a clinical anti-inflammatory effect. No specified mechanism reached the coverage requirement.
Depth
The main assigned contribution concerns oxidative and mitochondrial stress; this classification does not prove a clinical anti-inflammatory effect.
Breadth
No specified mechanism reached the saved coverage requirement.
Evidence82
Astaxanthin leads the saved comparison. Recognized amounts and preparations do not resolve the clinical and biomarker limitations.
Evidence strength
Astaxanthin leads the saved evidence comparison, while the supplied population and biomarker limitations constrain expected benefit.
Studied preparation
The saved comparison recognizes the qualifying preparation; this does not establish that the full product reproduces a clinical trial regimen.
Formulation logic100
The included contributions meet the saved amount requirement, with no missing required partner or identified ingredient conflict.
Partner coverage
No required partner was missing among the included contributions; this does not establish added benefit from combining ingredients.
Conflicts
No ingredient conflict was identified by the supplied checks.
Effective doses
All included contributions met the saved minimum amount requirement, which is not proof of a clinically effective dose.
Impact
High effect
Astaxanthin · 4 mg
Astaxanthin has limited oral evidence for skin responses to UV exposure and maintenance during seasonal deterioration. The 4 mg per serving receives partial amount recognition in the saved result, despite matching an exposure used in one small trial. Small samples and surrogate endpoints limit expectations; these findings do not establish sunscreen-equivalent protection or general reversal of skin aging.
How this product is rated for Skin Health
Ingredient fit73
The relevant ingredients receive partial amount recognition because of smaller or unresolved amounts. Other actives and links to additional goals also affect focus.
Goal fit
The relevant ingredients provide the recognized connection; other actives and links to additional goals reduce the product’s focus here.
Dose adequacy
Smaller or unresolved included amounts limit the serving comparison, without establishing lack of all biological activity.
Pathways19
The strongest recognized connection is to UV-related antioxidant findings. It does not reach the supplied coverage threshold.
Depth
The strongest recognized connection is to UV-related antioxidant findings.
Breadth
The limited contribution does not reach the supplied coverage threshold for any route.
Evidence87
Astaxanthin leads the saved evidence finding, with limited small-study support for UV and seasonal skin endpoints.
Evidence strength
Astaxanthin leads the saved evidence finding, with limited small-study support for UV and seasonal skin endpoints.
Studied preparation
The saved finding recognizes the included preparation as studied; that recognition does not resolve the specific applicability limitations described for each ingredient.
Formulation logic100
No unmet partner or configured conflict was identified. Included ingredients meet the saved amount threshold.
Partner coverage
No unmet required partner is identified for the included ingredients; this does not establish synergy.
Conflicts
No configured ingredient conflict was matched in the supplied findings.
Effective doses
The ingredients included in this check meet its amount threshold, without establishing proven cosmetic improvement.
Impact
High effect
Astaxanthin · 4 mg
Astaxanthin may help maintain selected aspects of skin condition during seasonal deterioration. The supplied sponsor-funded study in women reported maintenance and selected subgroup findings, with limited support for large differences between groups. The 4 mg per serving is below that study's lower daily exposure. These findings concern skin appearance rather than lifespan.
How this product is rated for Longevity
Ingredient fit73
Astaxanthin provides a focused connection with visible skin outcomes.
Goal fit
Astaxanthin provides a focused connection with visible skin outcomes.
Dose adequacy
Astaxanthin provides a partial amount comparison and is below the lower exposure in the supplied skin trial.
Pathways40
The saved findings place astaxanthin under antioxidant defence.
Depth
The saved findings place astaxanthin under antioxidant defence.
Breadth
One route reaches substantial coverage; broad coverage of other aging-related routes is limited.
Evidence82
Astaxanthin's evidence concerns limited skin-maintenance outcomes in women.
Evidence strength
Astaxanthin's evidence concerns limited skin-maintenance outcomes in women.
Studied preparation
The declared astaxanthin amount is recognized; algal source alone does not establish formulation superiority.
Formulation logic100
The included ingredients need no missing partner, and no configured ingredient conflict was found.
Partner coverage
The included ingredients work independently or have their required partner.
Conflicts
No configured ingredient conflict was found.
Effective doses
All included ingredients meet the saved minimum amount comparison; this does not prove a clinically effective anti-aging dose.
Impact
High effect
Astaxanthin · 4 mg
Astaxanthin may influence triglycerides and HDL cholesterol. The supplied support comes from a small study in adults with mildly elevated blood lipids, without LDL improvement or evidence of fewer cardiovascular events. The saved findings recognize its declared active amount, but the limited study base keeps expectations modest. Its 4 mg per serving receives partial amount recognition.
How this product is rated for Cardiovascular Support
Ingredient fit73
The relevant ingredients give this formula a clear cardiovascular connection, although it is linked to several goals.
Goal fit
The relevant ingredients give this formula a clear cardiovascular connection, although it is linked to several goals.
Dose adequacy
The counted ingredients receive partial amount recognition against the saved comparison anchors, which do not measure the size of a clinical benefit.
Pathways19
The supplied findings concentrate on triglyceride metabolism. The contribution remains below the saved breadth threshold.
Depth
The strongest supplied connection is triglyceride metabolism.
Breadth
No cardiovascular aspect reaches the saved coverage threshold, despite a limited triglyceride-related contribution.
Evidence79
Astaxanthin provides the strongest recognized evidence here, limited to the contexts and outcomes described for that ingredient.
Evidence strength
Astaxanthin provides the strongest recognized evidence here, limited to the contexts and outcomes described for that ingredient.
Studied preparation
The ingredients counted at meaningful amounts are recognized as studied preparations in the saved findings.
Formulation logic100
The counted ingredients have no missing required partner or listed conflict, and reach the saved minimum amount threshold.
Partner coverage
The counted ingredients can contribute without a missing required partner.
Conflicts
No listed ingredient conflict was triggered by the supplied facts.
Effective doses
All ingredients counted in this finding reach its minimum amount threshold; that threshold is a comparison convention, not proof of effectiveness.
Impact
High effect
Astaxanthin · 4 mg
Astaxanthin has limited findings for visual performance during display use, with favorable results confined to adults aged at least 40 in one small trial. The 4 mg serving is below that trial’s 9 mg daily exposure and does not establish the same effect.
How this product is rated for Eye Health
Ingredient fit73
Astaxanthin provide the saved connections, with usable serving amounts determining the extent of the comparison.
Goal fit
Astaxanthin provides the relevant ingredient connection.
Dose adequacy
The declared serving amounts provide uneven contributions; the amount comparison does not establish a proven vision-support dose.
Pathways17
The represented areas describe the supplied eye-related ingredient roles, without establishing prevention or treatment of eye disease.
Depth
The strongest represented area is focusing-muscle function. This describes ingredient roles rather than demonstrated improvement in vision.
Breadth
No area reaches the comparison threshold.
Evidence70
The supplied human findings concern selected visual-performance outcomes or defined clinical combinations, limiting transfer to routine adult vision support.
Evidence strength
Astaxanthin supplies the leading evidence contribution, with benefits limited by the populations and outcomes studied.
Studied preparation
The qualifying ingredient preparations match the saved comparison; this does not extend results to routine adult vision improvement.
Formulation logic100
The supplied partner and ingredient-conflict checks concern formulation compatibility rather than clinical eligibility for an eye-health regimen.
Partner coverage
The contributing ingredients can act independently or have the partners required by the supplied findings.
Conflicts
No configured ingredient conflict was identified; this is a limited interaction check.
Effective doses
All contributing ingredients meet the amount threshold used for this comparison, which is not a proven vision-support dose.
Impact
High effect
Astaxanthin · 4 mg
Astaxanthin's antioxidant activity offers a biological connection to cognitive health, but the supplied trial did not establish clear cognitive superiority to placebo. The 4 mg per serving receives partial recognition in the saved exposure comparison. It does not establish an effective cognitive dose or a reliable improvement in memory or attention.
How this product is rated for Cognitive Support
Ingredient fit73
The relevant ingredients receive amount recognition to varying degrees. Their cognitive relevance remains subject to the specific scientific limitations described above.
Goal fit
The declared relevant ingredients account for the formulation's cognitive focus, although the product is linked to other goals.
Dose adequacy
The recognized amounts receive partial overall exposure recognition, so they do not fully match the saved reference comparison.
Pathways19
The saved findings associate oxidative and inflammatory protection with this formulation, without establishing a demonstrated cognitive effect.
Depth
The main recognized connection is oxidative and inflammatory protection; this finding does not prove improved cognitive performance.
Breadth
No specified pathway reaches the saved coverage threshold, despite a partial connection.
Evidence79
Astaxanthin provides the strongest recognized evidence contribution. The supplied scientific limitations still constrain expectations for cognitive benefit.
Evidence strength
Astaxanthin supplies the strongest recognized evidence contribution, while the supplied context limits claims of routine cognitive improvement.
Studied preparation
The saved finding accepts the recognized preparations; this does not establish that all populations or outcomes would benefit.
Formulation logic100
The recognized ingredients have no missing partners or configured conflicts and meet the minimum amount threshold.
Partner coverage
The recognized ingredients meet the partner requirements without any missing required partner.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
All ingredients included in this check reach its minimum amount threshold, which is not proof of an effective cognitive dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 5 {Calories} | |
natural Astaxanthin (Haematococcus pluvialis extract) | 4 mg |
Astaxanthin (Haematococcus pluvialis extract) · 4 mg OverallScore78
A serving provides 4 mg of astaxanthin. The saved facts identify Haematococcus pluvialis as its source, and the whole-product serving costs about $0.19.
How this ingredient is rated
Active Ingredient Quality & Bioavailability60
Haematococcus pluvialis algae is identified as the astaxanthin source in the saved facts.
Biological Source Quality
Haematococcus pluvialis algae is identified as the astaxanthin source in the saved facts.
Formulation Technology
No liposomal or water-dispersible claim is recorded in the saved facts.
Branded Ingredient Standard
The saved facts identify a Haematococcus algae source but do not record a branded astaxanthin claim.
Dose, Safety & Label Transparency84
A serving provides 4 mg of astaxanthin. A stabilizer is recorded, but protective packaging cannot be established from the saved facts.
Clinical Potency per Serving
A serving provides 4 mg of astaxanthin.
Active Astaxanthin Yield Transparency
The saved facts record 4 mg of active astaxanthin per serving.
Ingredient Stability & Packaging
A stabilizer is recorded, but protective packaging cannot be established from the saved facts.
Value100
The whole-product price works out to about $0.05 per mg of astaxanthin.
Price per Milligram of Active Astaxanthin
The whole-product price works out to about $0.05 per mg of astaxanthin.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia.
- Antioxidant Lipid Supplement on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis.
- Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia.
- Effects of Astaxanthin Supplementation on Glycemic Control and Lipid Profile in Patients With Prediabetes and Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.
- Astaxanthin Supplemented with High-Intensity Functional Training Decreases Adipokines Levels and Cardiovascular Risk Factors in Men with Obesity.
- Effects of astaxanthin-rich Haematococcus pluvialis extract on cognitive function: a randomised, double-blind, placebo-controlled study.
- Effect of astaxanthin-rich extract derived from Paracoccus carotinifaciens on cognitive function in middle-aged and older individuals.
- The Effects of Astaxanthin on Cognitive Function and Neurodegeneration in Humans: A Critical Review.
- Effects of Astaxanthin Supplementation on Fatigue, Motor Function and Cognition: A Meta-Analysis of Randomized Controlled Trials.
- Astaxanthin and improvement of dementia: A systematic review of current clinical trials.
- Benefits and Safety of Astaxanthin in the Treatment of Mild-To-Moderate Dry Eye Disease.
- Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double-Blind Placebo-Controlled Trial.
- Effects of diet containing astaxanthin on visual function in healthy individuals: a randomized, double-blind, placebo-controlled, parallel study.
- Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential.
- Nutritional Supplementation for Myopia Prevention and Control: A Systematic Review of Randomized Controlled Trials.
- The anti-inflammatory and antioxidant effects of astaxanthin as an adjunctive therapy in community-acquired pneumonia: a randomized controlled trial.
- The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review.
- Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial.
- Astaxanthin Modulates Inflammation in Type 2 Diabetes via Regulation of microRNAs, Lysophosphatidylcholine, and α-Hydroxybutyrate.
- Redox-sensitive miRNAs and Humanin could mediate effects of exercise and astaxanthin on oxidative stress and inflammation in type 2 diabetes.